HIGHLIGHTS
- who: Eman A. Ahmed and colleagues from the Department of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Institute for Chemistry, Humboldt Universitu00e4t zu Berlin, Brook-Taylor-Str2, Berlin, Germany have published the research work: Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis, in the Journal: (JOURNAL) of 11/Oct/2022
- what: The study aimed to compare the metabolic signature between NASH and NASH-HCC patients to explore novel metabolic that might modulate progression in NASH patients. The study showed a significant increase in serum AST levels . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.